These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 35736358)

  • 21. Subsequent primary cancers after basal-cell carcinoma: A nationwide study in Finland from 1953 to 1995.
    Milán T; Pukkala E; Verkasalo PK; Kaprio J; Jansén CT; Koskenvuo M; Teppo L
    Int J Cancer; 2000 Jul; 87(2):283-8. PubMed ID: 10861488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cutaneous malignancies: BCC, SCC, and MM.
    Vargo N
    Dermatol Nurs; 2006 Apr; 18(2):183, 200. PubMed ID: 16708685
    [No Abstract]   [Full Text] [Related]  

  • 23. Management of non-melanoma skin cancer.
    Lazareth V
    Semin Oncol Nurs; 2013 Aug; 29(3):182-94. PubMed ID: 23958216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Basal cell carcinoma of the scalp resulting in spine metastasis in a black patient.
    Oram Y; Orengo I; Alford E; Green LK; Rosen T; Netscher DT
    J Am Acad Dermatol; 1994 Nov; 31(5 Pt 2):916-20. PubMed ID: 7962748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Basal cell carcinomas].
    Renaud-Vilmer C; Basset-Seguin N
    Rev Prat; 2014 Jan; 64(1):37-44. PubMed ID: 24649544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence of Basal Cell Carcinoma and Squamous Cell Carcinoma in Patients on Antiprogrammed Cell Death-1 Therapy for Metastatic Melanoma.
    Zhao CY; Hwang SJE; Anforth R; Carlos G; Chou S; Carlino M; Fernández-Peñas P
    J Immunother; 2018 Sep; 41(7):343-349. PubMed ID: 29939876
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predicting the Risk of a Second Basal Cell Carcinoma.
    Verkouteren JAC; Smedinga H; Steyerberg EW; Hofman A; Nijsten T
    J Invest Dermatol; 2015 Nov; 135(11):2649-2656. PubMed ID: 26121210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Basal cell carcinoma-treatments for the commonest skin cancer.
    Berking C; Hauschild A; Kölbl O; Mast G; Gutzmer R
    Dtsch Arztebl Int; 2014 May; 111(22):389-95. PubMed ID: 24980564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pediatric basal cell carcinoma: case reports and literature review.
    Efron PA; Chen MK; Glavin FL; Kays DW; Beierle EA
    J Pediatr Surg; 2008 Dec; 43(12):2277-80. PubMed ID: 19040953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genome-wide association studies and polygenic risk scores for skin cancer: clinically useful yet?
    Roberts MR; Asgari MM; Toland AE
    Br J Dermatol; 2019 Dec; 181(6):1146-1155. PubMed ID: 30908599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines.
    Peris K; Fargnoli MC; Garbe C; Kaufmann R; Bastholt L; Seguin NB; Bataille V; Marmol VD; Dummer R; Harwood CA; Hauschild A; Höller C; Haedersdal M; Malvehy J; Middleton MR; Morton CA; Nagore E; Stratigos AJ; Szeimies RM; Tagliaferri L; Trakatelli M; Zalaudek I; Eggermont A; Grob JJ;
    Eur J Cancer; 2019 Sep; 118():10-34. PubMed ID: 31288208
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Parkinson's Disease, Melanoma, and Keratinocyte Carcinoma: A Population-Based Study.
    Lerman S; Amichai B; Weinstein G; Shalev V; Chodick G
    Neuroepidemiology; 2018; 50(3-4):168-173. PubMed ID: 29566384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dermoscopy in the diagnosis and management of basal cell carcinoma.
    Lallas A; Apalla Z; Ioannides D; Argenziano G; Castagnetti F; Moscarella E; Longo C; Palmieri T; Ramundo D; Zalaudek I
    Future Oncol; 2015 Nov; 11(22):2975-84. PubMed ID: 26450622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of Shiny White Blotches and Strands With Nonpigmented Basal Cell Carcinoma: Evaluation of an Additional Dermoscopic Diagnostic Criterion.
    Navarrete-Dechent C; Bajaj S; Marchetti MA; Rabinovitz H; Dusza SW; Marghoob AA
    JAMA Dermatol; 2016 May; 152(5):546-52. PubMed ID: 26792406
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is early detection of basal cell carcinoma worthwhile? Systematic review based on the WHO criteria for screening.
    Hoorens I; Vossaert K; Ongenae K; Brochez L
    Br J Dermatol; 2016 Jun; 174(6):1258-65. PubMed ID: 26872563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increase in basal cell carcinoma incidence steepest in individuals with high socioeconomic status: results of a cancer registry study in The Netherlands.
    van Hattem S; Aarts MJ; Louwman WJ; Neumann HA; Coebergh JW; Looman CW; Nijsten T; de Vries E
    Br J Dermatol; 2009 Oct; 161(4):840-5. PubMed ID: 19438849
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiological and pathological aspects of skin cancer in North East of Romania.
    Andrese E; Solovăstru LG; Taranu T; Iancu LS
    Rev Med Chir Soc Med Nat Iasi; 2014; 118(2):457-62. PubMed ID: 25076715
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of prospectively collected presenting signs/symptoms of biopsy-proven melanoma, basal cell carcinoma, squamous cell carcinoma, and seborrheic keratosis in an elderly male population.
    Askari SK; Schram SE; Wenner RA; Bowers S; Liu A; Bangerter AK; Warshaw EM
    J Am Acad Dermatol; 2007 May; 56(5):739-47. PubMed ID: 17258839
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative aspects of melanoma and non-melanoma skin cancers in Japan.
    Ikeda S; Kiyohara Y; Mizutani H
    J Invest Dermatol; 1989 May; 92(5 Suppl):204S-209S. PubMed ID: 2715651
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Malignant melanoma and nonmelanoma skin cancers in Northrhine-Westphalia, Germany: a patient- vs. diagnosis-based incidence approach.
    Stang A; Ziegler S; Büchner U; Ziegler B; Jöckel KH; Ziegler V
    Int J Dermatol; 2007 Jun; 46(6):564-70. PubMed ID: 17550552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.